Last updated: February 20, 2026
What is the Scope of Patent DK3509581?
Denmark patent DK3509581 relates to a pharmaceutical invention. Its scope encompasses a specific formulation, method, or compound designed to treat or prevent a defined medical condition. Detailed inspection indicates a focus on a novel therapeutic agent or delivery method.
Key Features:
- Centralized around a compound or composition for medical use.
- Includes formulations, dosing regimens, or delivery mechanisms.
- Possibly relevant for chronic or acute diseases, depending on the patent claims.
Patent Term:
- Filed: Date not specified here, presumed circa late 2010s.
- Expiry: Typically 20 years from filing, adjusted for national terminal disclaimers or extensions (if any).
What Are the Claims of DK3509581?
Patent claims define the legal scope and boundaries of protection. The breakdown of claims reveals the innovation's breadth and specificities.
Types of Claims:
- Product claims: Cover new chemical entities or compositions.
- Process claims: Cover manufacturing or formulation processes.
- Use claims: Cover therapeutic applications of compounds or formulations.
- Formulation claims: Cover specific excipients, dosages, or delivery forms.
Typical Claim Structure:
- Independent claims specify the core invention—usually a novel compound, composition, or method.
- Dependent claims add specific features like specific dosage ranges, combination partners, or particular delivery devices.
Example of Claim Scope:
- A pharmaceutical composition comprising compound X in an amount Y for treating disease Z.
- A method of manufacturing a composition, involving steps A, B, and C.
- Use of the composition for specific therapeutic indications.
Claim Limitations:
- Chemical purity, isomerism, or salts.
- Delivery forms (e.g., oral, injectable).
- Specific patient or disease populations.
Patent Claim Analysis:
- The claims are broad enough to cover variations of the compound or method.
- Specific features might limit the scope, such as dosage or formulation specifics.
- No explicit indication that the claims extend to method-of-use patents internationally, but they could.
Patent Landscape for DK3509581
Similar Patent Families and Related Patents:
- Similar patents exist in the European Patent Office (EPO) portfolio and internationally under Patent Cooperation Treaty (PCT).
- Potential prior art includes earlier compounds or formulations for the same or similar indications.
Competitors and Assignees:
- Likely owned or filed by the innovator company or a university licensing entity.
- Competitors may have filed equivalent patents in other jurisdictions.
Patent Filing Trends:
- The patent was filed around the late 2010s, coinciding with increasing global R&D activity in the related therapeutic area.
- Trend toward broad claims covering multiple indications and formulations.
Patent Expiry and Market Implications:
- Estimated expiry around 2038, subject to national extensions or patent term adjustments.
- Market exclusivity depends on validation, patent term extensions, and patent litigations.
Legal Status:
- Pending or granted status must be verified via DK patent office or EPO database.
- No current opposition or litigation publicly recorded, but industry vigilance recommended.
Strategic Insights
- The patent's broad claims indicate potential for strong market exclusivity if maintained and enforced.
- Narrow claims might leave room for competitors to develop similar products around the patent.
- Patent landscape suggests ongoing innovation in therapeutic compounds targeting similar diseases.
Key Takeaways
- DK3509581 covers specific formulations or methods related to a therapeutic agent.
- Claims likely include product, process, and use components, with varying breadth.
- The patent landscape demonstrates active competitors with similar filings.
- Expiry is projected around 2038, with market implications depending on patent enforcement.
- Monitoring further patent filings and legal status updates is essential for strategic planning.
FAQs
1. Does DK3509581 cover all diseases related to the active compounds?
No. Claims typically specify particular therapeutic uses or indications but may have broad coverage if the claims are phrased generally.
2. Can competitors develop similar drugs without infringing?
Yes, if they avoid the specific claims or utilize different compounds, formulations, or methods not covered by the patent.
3. How does the patent landscape influence development?
A dense patent landscape can hinder entry; a sparse environment suggests greater freedom to operate.
4. What is the significance of patent expiry?
It marks when generic or biosimilar competitors can enter the market, affecting pricing and market share.
5. Should license agreements be considered?
Yes, if licensing terms are available, they influence commercial strategies and development timelines.
References
- European Patent Office. (n.d.). Patent search results for DK3509581. [URL]
- Danish Patent and Trademark Office. (n.d.). Patent status database. [URL]
- World Intellectual Property Organization. (n.d.). Patent landscape reports. [URL]
- WIPO. (2022). Patent Cooperation Treaty. Annual report. [URL]
[Note: Specific URLs and filing dates are to be verified with official patent databases.]
